Dr Anne Neville | Postdoctoral Fellow

This person is a member of Sanger Institute Alumni.

Neville, Anne

I investigate the inherent properties of commensal bacteria with a view to developing treatments for intestinal diseases caused by enteric pathogens, and to improve and maintain gut health.

My research is focused on developing therapeutic and prophylactic microbiota-based interventions that will prevent or ameliorate intestinal diseases caused by opportunistic enteric pathogens.

I am currently working on understanding the basis for colonisation resistance to Clostridium difficile in healthy individuals and in harnessing this knowledge to develop new microbe-based therapeutics as an alternative to antibiotics, for the treatment of C. difficile disease.

During a previous appointment, I worked on characterising the effect of selected probiotics on Candida albicans, a commensal yeast species that is capable of causing life-threathening disseminated disease under dysbiotic conditions or in immunocompromised individuals.

Both of these opportunistic pathogens may be carried asymptomatically and in low numbers by healthy individuals. The natural colonisation resistance of an intact healthy gut microbiota is normally an effective barrier against infections caused by these microbes. However, when this natural barrier is compromised, for example by an antibiotic treatment which disrupts the structure of the intestinal microbiota, disease caused by these species may ensue.

I have been involved in establishing in vivo model systems to enable the study of microbe-based interventions on intestinal colonisation by these pathobionts.

I am also interested in understanding the basic biology of autochthonous gut bacteria. During my PhD, I studied flagellate species of the genera Lactobacillus, Roseburia and Eubacterium. I sought to understand the genetic basis for flagellum biosynthesis and motility in these species and the impact of flagellin production (a microbe associated molecular pattern recognised by Toll-Like Receptor 5) on the interaction of these bacteria with their host.


  • Candida albicans commensalism in the gastrointestinal tract.

    Neville BA, d'Enfert C and Bougnoux ME

    FEMS yeast research 2015

  • Detection and genomic characterization of motility in Lactobacillus curvatus: confirmation of motility in a species outside the Lactobacillus salivarius clade.

    Cousin FJ, Lynch SM, Harris HM, McCann A, Lynch DB et al.

    Applied and environmental microbiology 2015;81;4;1297-1308

  • Carbohydrate catabolic flexibility in the mammalian intestinal commensal Lactobacillus ruminis revealed by fermentation studies aligned to genome annotations.

    O'Donnell MM, Forde BM, Neville B, Ross PR and O'Toole PW

    Microbial cell factories 2011;10 Suppl 1;S12

  • Genome sequences and comparative genomics of two Lactobacillus ruminis strains from the bovine and human intestinal tracts.

    Forde BM, Neville BA, O'Donnell MM, Riboulet-Bisson E, Claesson MJ et al.

    Microbial cell factories 2011;10 Suppl 1;S13

  • Probiotic properties of Lactobacillus salivarius and closely related Lactobacillus species.

    Neville BA and O'Toole PW

    Future microbiology 2010;5;5;759-74

Neville, Anne
Anne's Timeline

Post-doctoral researcher. Wellcome Trust Sanger Institute, Hinxton, UK.


Post-doctoral researcher. Institut Pasteur, Paris, France.

PhD (Microbiology). University College Cork, Cork, Ireland.


BSc (Genetics). University College Cork, Cork, Ireland.